hu.MAP 3.0: Complex View
Human Protein Complex Map
Search for a protein
Complex: huMAP3_10527.1
Confidence: Medium High  
ProteinsGenename | Protein Name | Uniprot Annotation Score | Links |
---|---|---|---|
ENSA | Alpha-endosulfine (ARPP-19e) | 5 | UniProt   NCBI |
XPA | DNA repair protein complementing XP-A cells (Xeroderma pigmentosum group A-complementing protein) | 5 | UniProt   NCBI |
SLX4 | Structure-specific endonuclease subunit SLX4 (BTB/POZ domain-containing protein 12) | 5 | UniProt   NCBI |
ERCC1 | DNA excision repair protein ERCC-1 | 5 | UniProt   NCBI |
ERCC4 | DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) | 5 | UniProt   NCBI |
Enrichments
Term ID | Corrected Pval | Fraction Complex Coverage | Proteins | Term Name |
---|---|---|---|---|
  CORUM:531 | 2.80233355908e-09 | 0.6 | ERCC1 XPA ERCC4 | XPA-ERCC1-ERCC4 complex |
  GO:0000109 | 4.33992010508e-08 | 0.8 | ERCC4 ERCC1 XPA SLX4 | nucleotide-excision repair complex |
  WP:WP5114 | 1.79216443484e-07 | 0.8 | ERCC4 ERCC1 XPA SLX4 | Nucleotide excision repair in xeroderma pigmentosum |
  GO:0000110 | 9.61200410764e-07 | 0.6 | ERCC1 XPA ERCC4 | nucleotide-excision repair factor 1 complex |
  GO:0070522 | 9.61200410764e-07 | 0.6 | ERCC1 SLX4 ERCC4 | ERCC4-ERCC1 complex |
  CORUM:2220 | 1.36501667663e-05 | 0.4 | ERCC1 ERCC4 | RAD52-ERCC4-ERCC1 complex |
  WP:WP4753 | 1.48411025729e-05 | 0.6 | ERCC1 XPA ERCC4 | Nucleotide excision repair |
  KEGG:03460 | 1.71122661794e-05 | 0.6 | ERCC1 SLX4 ERCC4 | Fanconi anemia pathway |
  REAC:R-HSA-6783310 | 2.03584684634e-05 | 0.6 | ERCC1 SLX4 ERCC4 | Fanconi Anemia Pathway |
  KEGG:03420 | 2.86326141069e-05 | 0.6 | ERCC1 XPA ERCC4 | Nucleotide excision repair |
  REAC:R-HSA-5696400 | 3.31378787787e-05 | 0.6 | ERCC1 XPA ERCC4 | Dual Incision in GG-NER |
  REAC:R-HSA-5696395 | 3.5683276241e-05 | 0.6 | ERCC1 XPA ERCC4 | Formation of Incision Complex in GG-NER |
  CORUM:368 | 4.09448956317e-05 | 0.4 | ERCC1 ERCC4 | ERCC1-ERCC4-MSH2 complex |
  CORUM:7295 | 4.09448956317e-05 | 0.4 | ERCC1 XPA | ERCC1-RPA1-XPA complex |
  HP:0001034 | 6.43550146138e-05 | 0.8 | ERCC4 ERCC1 XPA SLX4 | Hypermelanotic macule |
  HP:0007400 | 0.000115326413283 | 0.8 | ERCC4 ERCC1 XPA SLX4 | Irregular hyperpigmentation |
  HP:0012733 | 0.000122437834659 | 0.8 | ERCC4 ERCC1 XPA SLX4 | Macule |
  REAC:R-HSA-6782135 | 0.000129211329951 | 0.6 | ERCC1 XPA ERCC4 | Dual incision in TC-NER |
  REAC:R-HSA-73894 | 0.000150476434856 | 0.8 | ERCC4 ERCC1 XPA SLX4 | DNA Repair |
  GO:0006289 | 0.000186904603412 | 0.8 | ERCC4 ERCC1 XPA SLX4 | nucleotide-excision repair |
  REAC:R-HSA-6781827 | 0.000226554396442 | 0.6 | ERCC1 XPA ERCC4 | Transcription-Coupled Nucleotide Excision Repair (TC-NER) |
  WP:WP4946 | 0.00027954510039 | 0.6 | ERCC1 XPA ERCC4 | DNA repair pathways full network |
  REAC:R-HSA-5696399 | 0.000284390695808 | 0.6 | ERCC1 XPA ERCC4 | Global Genome Nucleotide Excision Repair (GG-NER) |
  HP:0000953 | 0.0003677422453 | 0.8 | ERCC4 ERCC1 XPA SLX4 | Hyperpigmentation of the skin |
  HP:0002860 | 0.000447946694857 | 0.6 | ERCC4 XPA SLX4 | Squamous cell carcinoma |
  REAC:R-HSA-5696398 | 0.000630278165562 | 0.6 | ERCC1 XPA ERCC4 | Nucleotide Excision Repair |
  REAC:R-HSA-5693567 | 0.000932817738425 | 0.6 | ERCC1 SLX4 ERCC4 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) |
  HP:0006313 | 0.000961529670085 | 0.4 | ERCC1 ERCC4 | Widely spaced primary teeth |
  REAC:R-HSA-5693538 | 0.00107666549853 | 0.6 | ERCC1 SLX4 ERCC4 | Homology Directed Repair |
  HP:0000135 | 0.00116306653983 | 0.8 | ERCC4 ERCC1 XPA SLX4 | Hypogonadism |
  HP:0006334 | 0.001345957274 | 0.4 | ERCC1 ERCC4 | Hypoplasia of the primary teeth |
  HP:0000509 | 0.00153309167261 | 0.6 | ERCC1 XPA ERCC4 | Conjunctivitis |
  HP:0000992 | 0.00169289796817 | 0.6 | ERCC1 XPA ERCC4 | Cutaneous photosensitivity |
  HP:0025337 | 0.00174852750004 | 0.6 | ERCC1 XPA ERCC4 | Red eye |
  HP:0010649 | 0.00179436403841 | 0.4 | XPA ERCC4 | Flat nasal alae |
  REAC:R-HSA-5693532 | 0.0019808748776 | 0.6 | ERCC1 SLX4 ERCC4 | DNA Double-Strand Break Repair |
  HP:0001000 | 0.00229405005158 | 0.8 | ERCC4 ERCC1 XPA SLX4 | Abnormality of skin pigmentation |
  HP:0001053 | 0.00258565436429 | 0.6 | ERCC4 XPA SLX4 | Hypopigmented skin patches |
  GO:1990599 | 0.00468200720083 | 0.4 | ERCC1 ERCC4 | 3' overhang single-stranded DNA endodeoxyribonuclease activity |
  GO:0061819 | 0.00468200720083 | 0.4 | ERCC1 ERCC4 | telomeric DNA-containing double minutes formation |
  GO:1901255 | 0.00468200720083 | 0.4 | XPA ERCC4 | nucleotide-excision repair involved in interstrand cross-link repair |
  GO:1905764 | 0.00468200720083 | 0.4 | ERCC1 ERCC4 | regulation of protection from non-homologous end joining at telomere |
  GO:1905765 | 0.00468200720083 | 0.4 | ERCC1 ERCC4 | negative regulation of protection from non-homologous end joining at telomere |
  HP:0009755 | 0.00582689447108 | 0.4 | XPA ERCC4 | Ankyloblepharon |
  HP:0008373 | 0.00590636383162 | 0.8 | ERCC4 ERCC1 XPA SLX4 | Puberty and gonadal disorders |
  HP:0000502 | 0.00593647702079 | 0.6 | ERCC1 XPA ERCC4 | Abnormal conjunctiva morphology |
  HP:0000674 | 0.00672241921037 | 0.4 | ERCC1 ERCC4 | Anodontia |
  HP:0003079 | 0.00672241921037 | 0.4 | XPA ERCC4 | Defective DNA repair after ultraviolet radiation damage |
  GO:0032205 | 0.00683974211741 | 0.6 | ERCC1 SLX4 ERCC4 | negative regulation of telomere maintenance |
  HP:0000680 | 0.00768171284681 | 0.4 | ERCC1 ERCC4 | Delayed eruption of primary teeth |
  HP:0010468 | 0.00819982205473 | 0.6 | ERCC4 XPA SLX4 | Aplasia/Hypoplasia of the testes |
  HP:0006739 | 0.00870474912182 | 0.4 | XPA ERCC4 | Squamous cell carcinoma of the skin |
  REAC:R-HSA-5685938 | 0.00900400267976 | 0.4 | ERCC1 ERCC4 | HDR through Single Strand Annealing (SSA) |
  HP:0045058 | 0.0105962255115 | 0.6 | ERCC4 XPA SLX4 | Abnormality of the testis size |
  KEGG:01524 | 0.0108758996329 | 0.4 | ERCC1 XPA | Platinum drug resistance |
  HP:0003254 | 0.0109419445801 | 0.4 | XPA ERCC4 | Abnormality of DNA repair |
  HP:0100533 | 0.0115529971699 | 0.6 | ERCC1 XPA ERCC4 | Inflammatory abnormality of the eye |
  HP:0000621 | 0.0121560512731 | 0.4 | XPA ERCC4 | Entropion |
  HP:0000524 | 0.0121560512731 | 0.4 | XPA ERCC4 | Conjunctival telangiectasia |
  HP:0008069 | 0.0127746024565 | 0.6 | ERCC4 XPA SLX4 | Neoplasm of the skin |
  HP:0002818 | 0.0132000411118 | 0.6 | ERCC1 SLX4 ERCC4 | Abnormal morphology of the radius |
  HP:0000028 | 0.0133683046288 | 0.8 | ERCC4 ERCC1 XPA SLX4 | Cryptorchidism |
  HP:0001010 | 0.0134162347773 | 0.6 | ERCC4 XPA SLX4 | Hypopigmentation of the skin |
  HP:0001029 | 0.0134337956242 | 0.4 | XPA ERCC4 | Poikiloderma |
  GO:1904506 | 0.0140440992017 | 0.4 | ERCC1 ERCC4 | negative regulation of telomere maintenance in response to DNA damage |
  HP:0000080 | 0.014110537422 | 0.8 | ERCC4 ERCC1 XPA SLX4 | Abnormality of reproductive system physiology |
  HP:0004493 | 0.0147751514018 | 0.4 | XPA ERCC4 | Craniofacial hyperostosis |
  HP:0005522 | 0.0147751514018 | 0.4 | SLX4 ERCC4 | Pyridoxine-responsive sideroblastic anemia |
  HP:0000025 | 0.015708466597 | 0.6 | ERCC1 SLX4 ERCC4 | Functional abnormality of male internal genitalia |
  HP:0010469 | 0.0161800923797 | 0.4 | SLX4 ERCC4 | Absent testis |
  HP:0040072 | 0.0164434381168 | 0.6 | ERCC1 SLX4 ERCC4 | Abnormal forearm bone morphology |
  HP:0002973 | 0.0166933934022 | 0.6 | ERCC1 SLX4 ERCC4 | Abnormal forearm morphology |
  HP:0000518 | 0.0170972280008 | 0.8 | ERCC4 ERCC1 XPA SLX4 | Cataract |
  HP:0008054 | 0.0176485923371 | 0.4 | XPA ERCC4 | Abnormal morphology of the conjunctival vasculature |
  HP:0000517 | 0.0189122123602 | 0.8 | ERCC4 ERCC1 XPA SLX4 | Abnormal lens morphology |
  HP:0011355 | 0.0220157972203 | 0.8 | ERCC4 ERCC1 XPA SLX4 | Localized skin lesion |
  HP:0010293 | 0.0224351839587 | 0.4 | SLX4 ERCC4 | Aplasia/Hypoplasia of the uvula |
  HP:0012848 | 0.0224351839587 | 0.4 | SLX4 ERCC4 | Small intestinal stenosis |
  HP:0100867 | 0.0224351839587 | 0.4 | SLX4 ERCC4 | Duodenal stenosis |
  HP:0002827 | 0.0228469664256 | 0.6 | ERCC1 SLX4 ERCC4 | Hip dislocation |
  HP:0000613 | 0.0241059715815 | 0.6 | ERCC1 XPA ERCC4 | Photophobia |
  HP:0100760 | 0.0241576577336 | 0.4 | SLX4 ERCC4 | Clubbing of toes |
  HP:0002245 | 0.0241576577336 | 0.4 | SLX4 ERCC4 | Meckel diverticulum |
  HP:0005328 | 0.0241576577336 | 0.4 | ERCC1 ERCC4 | Progeroid facial appearance |
  GO:0003684 | 0.0250826699056 | 0.6 | ERCC1 XPA ERCC4 | damaged DNA binding |
  HP:0100587 | 0.0277928629638 | 0.4 | SLX4 ERCC4 | Abnormal preputium morphology |
  GO:1904431 | 0.0280843539964 | 0.4 | ERCC1 SLX4 | positive regulation of t-circle formation |
  HP:0012874 | 0.0307145475304 | 0.6 | ERCC1 SLX4 ERCC4 | Abnormal male reproductive system physiology |
  HP:0000568 | 0.0314726608058 | 0.6 | ERCC1 SLX4 ERCC4 | Microphthalmia |
  HP:0001924 | 0.0316815705386 | 0.4 | SLX4 ERCC4 | Sideroblastic anemia |
  HP:0000026 | 0.0316815705386 | 0.4 | ERCC1 ERCC4 | Male hypogonadism |
  HP:0000035 | 0.0329820764126 | 0.8 | ERCC4 ERCC1 XPA SLX4 | Abnormal testis morphology |
  HP:0200007 | 0.0362822138687 | 0.6 | ERCC1 SLX4 ERCC4 | Abnormal size of the palpebral fissures |
  HP:5200058 | 0.0362822138687 | 0.6 | ERCC1 XPA ERCC4 | Sensory hypersensitivity |
  HP:0006887 | 0.0379894907585 | 0.4 | XPA ERCC4 | Intellectual disability, progressive |
  HP:0001059 | 0.0402186552091 | 0.4 | XPA ERCC4 | Pterygium |
  HP:5200046 | 0.0415537333882 | 0.6 | ERCC1 XPA ERCC4 | Sensory behavioral abnormality |
  HP:0100579 | 0.0425110382594 | 0.4 | XPA ERCC4 | Mucosal telangiectasiae |
  HP:0040012 | 0.0425110382594 | 0.4 | SLX4 ERCC4 | Chromosome breakage |
  HP:0001549 | 0.0425110382594 | 0.4 | SLX4 ERCC4 | Abnormal ileum morphology |
  HP:0030311 | 0.043417085174 | 0.6 | ERCC1 SLX4 ERCC4 | Lower extremity joint dislocation |
  HP:0100887 | 0.043417085174 | 0.6 | ERCC1 SLX4 ERCC4 | Abnormality of globe size |
  HP:0004437 | 0.0472853555832 | 0.4 | XPA ERCC4 | Cranial hyperostosis |
  HP:0000554 | 0.0472853555832 | 0.4 | ERCC1 ERCC4 | Uveitis |
  HP:0007700 | 0.0488237559993 | 0.6 | ERCC1 SLX4 ERCC4 | Ocular anterior segment dysgenesis |
Edges
Protein 1 | Protein 2 | Score | ProteomeHD | Evidence |
---|---|---|---|---|
 ERCC4 |  ERCC1 | 0.999 | 0.24           | bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     youn_WMM     Malo     fraction     |
 ERCC4 |  XPA | 0.994 | 0.158           | bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     |
 ERCC1 |  XPA | 0.991 | 0.2           | bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     |
 ERCC4 |  SLX4 | 0.968 | 0.166           | hein_WMM     bioplex3_HEK293     bioplex_WMM     bioplex3_WMM     WMM_only     |
 ENSA |  XPA | 0.968 | 0.136           | bioplex3_WMM     bioplex3_HCT116     WMM_only     |
 SLX4 |  ERCC1 | 0.682 | 0.184           | bioplex ()     bioplex_WMM     bioplex3_WMM     |
 ERCC4 |  ENSA | 0.02 | 0.062           | bioplex3_WMM     gupta_WMM     WMM_only     |
 ERCC1 |  ENSA | 0.012 | 0.1           | bioplex3_WMM     youn_WMM     WMM_only     |
Related Complexes